BBGBloomberg·1hBusiness
score-0.35
Activist Investor AVI Pushes for Board Renewal at Japan's Rohto Pharmaceutical, Signaling Continued Shareholder Engagement Push
Original
UK Fund AVI Wants Chairman of Japan Drugmaker Rohto to Leave
“Activist shareholder demand framed as routine corporate governance action; 'wants to leave' and 'stay busy' language is matter-of-fact, not alarmist.”